Related Experiment Video
Updated: Dec 28, 2025

Simultaneous Laryngopharyngeal and Conventional Esophageal pH Monitoring
Published on: December 14, 2020
Internists' Misconceptions About PPIs: Increasing Knowledge and Implementing Guidelines.
1Department of Gastroenterology, Kaiser Permanente Southern California, San Diego, CA, USA.
Physicians frequently misunderstand proton-pump inhibitor (PPI) side effects, leading to incorrect prescribing. Many internists wrongly stopped PPIs for high-risk patients, highlighting a need for better drug information dissemination.
Area of Science:
- Internal Medicine
- Pharmacology
Background:
- Misconceptions regarding proton-pump inhibitor (PPI) adverse effects are prevalent among internists.
- These misconceptions have led to alterations in prescribing practices.
Purpose of the Study:
- To assess internists' understanding of PPI adverse effects in relation to upper gastrointestinal bleeding risk.
- To identify factors influencing physician prescribing behavior and information seeking.
Main Methods:
- Physicians were presented with four clinical scenarios involving upper gastrointestinal bleeding risk.
- Prescribing decisions regarding PPI discontinuation were analyzed based on patient risk factors.
Main Results:
- While 86% correctly discontinued PPIs for low-risk patients, 79% inappropriately discontinued them for high-risk patients (e.g., those with peptic ulcer history on aspirin).
- Physician self-assessment of knowledge was often inaccurate.
- Time constraints and unanswered clinical questions, particularly concerning medications, were common barriers.
Conclusions:
- Physician knowledge gaps regarding PPI adverse effects necessitate improved educational strategies.
- Disseminating accurate, scientific drug information more rapidly and systematically monitoring guideline use are crucial for enhancing guideline implementation.
Related Concept Videos
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Gastroesophageal Reflux Disease II: Clinical Features and Management
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

